World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
ImmuPharma plc in brief
ImmuPharma plc is a listed company in the Biotechnology industry, based in the UK. Its last known market value was $9 M (January 2024); there is no current figure. Its shares trade under the symbol IMM.L (LSE).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
World rank over time
▼ down 1,689 places since 2022
Rank in UK: #1,277 (Jan 2022) · #1,283 (Dec 2022) · #1,238 (Jul 2023) · #1,190 (Jan 2024)
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| ImmuPharma plc🇬🇧 | $9 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
How current the figures are
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 4, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at ImmuPharma plc? Verify and update this profile — free
Show ImmuPharma plc's ranking on your website Get the badge
The badge updates itself as the ranking changes.